Article Versions Notes

Merkx RIJ, Rijpkema M, Franssen GM, Kip A, Smeets B, Morgenstern A, Bruchertseifer F, Yan E, Wheatcroft MP, Oosterwijk E, et al. Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model. Pharmaceuticals. 2022; 15(5):570. https://doi.org/10.3390/ph15050570

Merkx, Robin I. J., Mark Rijpkema, Gerben M. Franssen, Annemarie Kip, Bart Smeets, Alfred Morgenstern, Frank Bruchertseifer, Eddie Yan, Michael P. Wheatcroft, Egbert Oosterwijk, and et al. 2022. "Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model" Pharmaceuticals 15, no. 5: 570. https://doi.org/10.3390/ph15050570

Merkx, R. I. J., Rijpkema, M., Franssen, G. M., Kip, A., Smeets, B., Morgenstern, A., Bruchertseifer, F., Yan, E., Wheatcroft, M. P., Oosterwijk, E., Mulders, P. F. A., & Heskamp, S. (2022). Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model. Pharmaceuticals, 15(5), 570. https://doi.org/10.3390/ph15050570